NCPE
@INFO_NCPE
132 Following 1.7K Followers 2K Posts
Latest posts 5
The NCPE has completed a full HTA of Durvalumab (Imfinzi®) in combination with gemcitabine and cisplatin is indicated for the first-line treatment of adults with unresectable or metastatic biliary tract cancer.(1/2)
The NCPE have completed a Rapid Review of Ribociclib (Kisqali®) in combination with an aromatase inhibitor (AI) is indicated for the adjuvant treatment of patients with hormone receptor positive (HR+), ...(1/2)
The NCPE have completed a Rapid Review of Eplontersen (Wainzua®) or the treatment of hereditary transthyretin-mediated amyloidosis (ATTRv) in adult patients with stage 1 or stage 2 polyneuropathy.(1/2)
